DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

MannKind Corp (NASDAQ: MNKD)

6.52 -0.30 (-4.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $6.52 -4.40%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.75
Previous Close $6.82
Daily Range $6.50 - $6.77
52-Week Range $3.80 - $11.48
Market Cap $2.6B
P/E Ratio -13.37
Dividend (Yield) $0.00 (0.0%)
Volume 6,443,437
Average Daily Volume 6,332,399
Current FY EPS -$0.32




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

Why Second Sight Medical Products Inc. Vaulted Higher Today

Second Sight Medical Products shares continue to surge higher.

Analysts Weigh In On MannKind Following Q4 Results

Analysts Weigh in on MannKind Following Q4 Results

MannKind's Financial Statements Can Be Scary To Most Investors

Are Sellers Wrong to Be Short MannKind Corp.?

MannKind Corporation's short interest has soared to more than 80 million shares.

An Objective, We Think, Up-To-Date Look At MannKind

Jefferies Expects Exciting 2015 For MannKind

More Insight Into MannKind's Near-Term Profitability

MannKind Reports Narrower Y/Y Loss in Q4, Afrezza in Focus - Analyst Blog

JPM Securities Picks Through Biotech News For Winners

See More MNKD News...

MNKD's Top Competitors

MNKD $6.52 (-4.40%)
Current stock: MNKD
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
BIIB $409.59 (-0.12%)
Current stock: BIIB